NeoGenomics Laboratories · 3 months ago
Accessioning Support Technician - Part Time, Temp
NeoGenomics Laboratories is a leading cancer reference laboratory that invests in its employees and promotes a purpose-driven mission. They are seeking an Accessioning Support Technician to ensure proper handling of specimens and support laboratory testing through various responsibilities.
BiotechnologyGeneticsHealth CareHealth DiagnosticsMedicalPharmaceutical
Responsibilities
Receives (opening packages) and sorts specimens for testing
Distribute cases to Leads to triage
Collecting cases and scanning (chain of custody) to other departments
Collecting paperwork and scan in Document locator
Monitors missed scans (locate and scans missing paperwork)
Assists in locating specimens (Fresh and FFPE)
Medical Records filing
Regular and Biohazard Trash check
Utilize chain of custody logs for slides, blocks and fresh samples, ensure appropriate chain of custody for blocks, slides and fresh samples is followed. Oversee Q/C workflow and reconciliation of blocks and the block log
Follow Department’s procedures including specimen routing and handling. Recognize and take appropriate action in response to missing or lost blocks and fresh samples and communicate these to Lead, Supervisor or Manager. Implement lost block and fresh samples process to locate missing blocks and fresh samples as required
Other duties as assigned by department Supervisor or Lead
Qualification
Required
High School Diploma or equivalent
Proficient with MS Office programs
Ability to communicate effectively
Strong organizational skills and attention to detail
Ability to work independently
Must be able to work in a fast paced, multi-tasking environment and maintain production and quality standards
Must be able to work in a biohazard environment and comply with safety policies and standards outlined in the Safety Manual
Company
NeoGenomics Laboratories
NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and oncology data solutions.
Funding
Current Stage
Public CompanyTotal Funding
$925.9M2021-05-05Post Ipo Equity· $200M
2020-04-30Post Ipo Equity· $125.4M
2020-04-30Post Ipo Debt· $175M
Leadership Team
Recent News
2026-01-04
Company data provided by crunchbase